Old Web
English
Sign In
Acemap
>
authorDetail
>
Yanqiu Wu
Yanqiu Wu
University of Oxford
Immunology
Innate lymphoid cell
Medicine
Fevipiprant
Physical therapy
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
2019
The Journal of Allergy and Clinical Immunology
Clare S. Hardman
Wentao Chen
Jian Luo
Paul Batty
Yi-Ling Chen
Janina Nahler
Yanqiu Wu
Ian D. Pavord
Veit J. Erpenbeck
David Andrew Sandham
Luzheng Xue
Graham S. Ogg
Show All
Source
Cite
Save
Citations (7)
Resistance to apoptosis underpins corticosteroid-insensitivity of group 2 innate lymphoid cells.
2019
The Journal of Allergy and Clinical Immunology
Jian Luo
Yanqiu Wu
Rahul Shrimanker
S Go
Y Ye
Clare S. Hardman
Janina Nahler
Chen Y-L.
Linda Stöger
N Zeng
Wei Liu
L Reed
Aviva M. Tolkovsky
Paul Klenerman
Graham S. Ogg
Ian D. Pavord
Luzheng Xue
Show All
Source
Cite
Save
Citations (0)
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
2018
European Respiratory Journal
Wentao Chen
Clare S. Hardman
Paul Batty
Jian Luo
Yanqiu Wu
Luzheng Xue
Graham S. Ogg
David Andrew Sandham
Veit J. Erpenbeck
Show All
Source
Cite
Save
Citations (0)
1